ArticleEJHaem2025

Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland.

Anders Rønneholt-Frederiksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.